- Home
- ELAB
ELAB
Elevai Labs Inc.
as 02-21-2025 4:00pm EST
Stocks
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEWPORT BEACH |
| Market Cap: | 6.6M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -61.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.60 - $166.00 | Next Earning Date: | 03-28-2025 |
| Revenue: | $2,446,161 | Revenue Growth: | 112.17% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Elevai Labs Inc. News
ELAB Breaking Stock News: Dive into ELAB Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists
GlobeNewswire
18 days ago
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
GlobeNewswire
22 days ago
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies
GlobeNewswire
23 days ago
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
GlobeNewswire
a month ago
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors
GlobeNewswire
a month ago
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium
GlobeNewswire
a month ago
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture
GlobeNewswire
a month ago
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
Compare ELAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELAB Elevai Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.